Device
HVPG
HVPG is a medical device with 4 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
2(50%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
1
25%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Completed(1)
Other(1)
Detailed Status
Recruiting2
Completed1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
2
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A1 (100.0%)
Trials by Status
completed125%
recruiting250%
unknown125%
Recent Activity
2 active trials
Showing 4 of 4
recruiting
3D-MRE for Assessing Cirrhosis, Advanced Chronic Liver Disease and Portal Hypertension
NCT05475015
recruiting
3D-MRE and 2D-MRE for Assessing Cirrhosis and Portal Hypertension
NCT06205992
unknown
A Novel Imaging Based Quantitative Model-aided Detection of Portal Hypertension in Patients With Cirrhosis (CHESS2104)
NCT05068492
completednot_applicable
Surrogate Markers of Portal Pressure
NCT02508298
Clinical Trials (4)
Showing 4 of 4 trials
NCT05475015
3D-MRE for Assessing Cirrhosis, Advanced Chronic Liver Disease and Portal Hypertension
NCT06205992
3D-MRE and 2D-MRE for Assessing Cirrhosis and Portal Hypertension
NCT05068492
A Novel Imaging Based Quantitative Model-aided Detection of Portal Hypertension in Patients With Cirrhosis (CHESS2104)
NCT02508298Not Applicable
Surrogate Markers of Portal Pressure
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4